Sequent Scientific LtdPharmaceuticalsINE807F01027Standalone₹249.90+5.10 (+2.08%)Jun-26
Valuation
Market Cap₹10.91K Cr
TTM PE175.81x
Forward PE144.03x
PEG5.58
Book Value₹16.13
P/B15.48x
TTM EPS₹1.42
Fwd EPS₹1.73
TTM Revenue₹1.10K Cr
TTM PAT₹59.73 Cr
TTM EBITDA₹177.54 Cr
TTM EBIT₹80.53 Cr
Last Qtr PAT₹20.92 Cr
Last Qtr EBITDA₹47.15 Cr
Last Qtr EBIT₹14.74 Cr
Profitability
ROE8.48%
ROCE8.00%
TTM NPM5.42%
TTM EBITDA %16.11%
Curr OPM5.91%
Last OPM9.61%
Curr NPM
Last NPM
Curr EPS₹0.48
Last EPS₹0.82
Balance sheet
Equity₹50.06 Cr
Reserve₹654.41 Cr
Total Debt₹483.38 Cr
D/E0.69x
Interest %6.88%
Curr Interest₹1.44 Cr
Price / range
Close₹249.65
vs 52W High-16.22%
vs 52W Low+39.94%
MA50
MA200
Returns
1D+2.11%
1W-2.86%
1M-1.87%
3M-1.61%
6M+28.02%
1Y+25.52%
2Y+40.25%
3Y+176.38%
5Y+14.10%
Diwali+19.62%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr148.173.58%
DIVISLAB9375.00₹2.49L Cr84.6217.55%
TORNTPHARM4840.00₹1.84L Cr78.8025.43%
ZYDUSLIFE1160.00₹1.16L Cr33.2112.96%
CIPLA1394.50₹1.13L Cr36.648.93%
LAURUSLABS1954.00₹1.06L Cr120.9216.46%
AUROPHARMA1734.00₹99.77K Cr38.796.84%
DRREDDY1185.00₹98.91K Cr148.681.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue353.69+761.2%372.49341.6434.0341.071,382.06
Other Income14.5919.7516.2911.7511.4866.26
Total Income368.28+600.8%392.24357.9345.7852.551,448.32
Interest1.442.533.560.831.0816.21
Expenditure-340.39-631.7%-343.49-306.06-39.74-46.52-1,287.89
PBDT000000
EBITDA47.15+2411.3%62.6970.34-2.64-2.04234.53
Depreciation-32.41-31.16-31.20-2.24-2.33-124.15
EBIT14.74+437.3%31.5339.14-4.88-4.37110.38
PBT27.89+483.5%48.7510.614.344.78116.22
Tax-6.97-12.94-10.69-1.26-1.41-40.35
Equity000050.070
OPM7.8913.093.1112.759.108.00
Net Profit20.92+520.8%35.81-0.083.083.3775.87
NPM5.919.61-0.029.056.415.00
EPS0.48+242.9%0.8200.120.141.75

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue1,382.06+675.3%178.26+5.8%168.52-24.3%222.69+1.4%219.63-17.3%265.46
Other Income66.2650.9445.9828.2427.6419.97
Total Income1,448.32+531.9%229.20+6.9%214.50-14.5%250.93+1.5%247.27-13.4%285.42
Expenditure-1,287.89-536.7%-202.27+3.0%-208.48+20.0%-260.67-12.6%-231.58+4.3%-241.98
Interest-16.21-3.96-4.36-2.51-1.61-2.68
PBDT000000
EBITDA234.53+2160.9%-11.38+57.3%-26.66-1.2%-26.35-3413.3%-0.75-102.1%35.29
Depreciation-124.15-8.67-8.94-9.12-9.59-9.13
EBIT110.38+650.5%-20.05+43.7%-35.60-0.4%-35.47-243.0%-10.34-139.5%26.16
PBT116.22+427.1%22.05+9287.5%-0.24+97.5%-9.75-162.1%15.69-61.6%40.89
Tax-40.35-6.250.863.67-0.89-8.77
Equity050.060000
OPM (%)8.009.620.00-4.006.0014.00
Net Profit75.87+380.2%15.80+2448.4%0.62+110.2%-6.08-141.1%14.80-53.9%32.11
NPM (%)5.006.890.00-2.006.0011.00
EPS (Rs)1.75+177.8%0.63+2000.0%0.03+112.5%-0.24-140.0%0.60-53.8%1.30
CEPS1.720.620.03-0.240.591.30

Consolidated

16 lines · 6 periods
MetricDec-25Sep-25Jun-25Mar-25Dec-24FY24-25
Revenue858.41+119.6%423.99441.42401.70390.811,551.37
Other Income13.982.153.871.665.8414.69
Total Income872.39+119.9%426.14445.29403.36396.651,566.06
Interest16.7513.5114.1615.1314.9560.75
Expenditure-758.06-95.3%-397.28-418.52-386.71-388.24-1,516.78
PBDT000000
EBITDA175.63+409.1%55.6852.1946.2434.50161.79
Depreciation-58.53-15.46-15.13-16.12-16.98-66.45
EBIT117.10+568.4%40.2237.0630.1217.5295.34
PBT73.07+802.1%27.1625.5216.318.1044.31
Tax-24.55-7.56-7.95-5.93-1.62-12.05
Equity0050.0750.06050.06
OPM8.386.375.734.042.042.83
Net Profit48.52+648.8%19.6017.5710.386.4832.26
NPM5.564.603.952.571.632.06
EPS0.89+535.7%0.590.570.370.140.88

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 24-25FY 23-24FY 22-23FY 21-22FY 20-21FY 19-20
Revenue1,551.37+13.3%1,369.73-3.6%1,420.91+0.6%1,412.82+3.8%1,361.62+15.5%1,179.24
Other Income14.6910.966.3910.858.3610.09
Total Income1,566.06+13.4%1,380.69-3.3%1,427.30+0.3%1,423.66+3.9%1,369.98+15.2%1,189.33
Expenditure-1,516.78-7.0%-1,417.94+5.5%-1,500.16-9.5%-1,370.28-11.9%-1,224.53-11.8%-1,095.26
Interest-60.75-48.09-35.52-15.77-24.38-35.71
PBDT000000
EBITDA161.79+163.4%61.42+413.5%11.96-89.1%109.40-48.4%212.07+24.5%170.31
Depreciation-66.45-61.54-55.69-51.09-50.60-50.62
EBIT95.34+79550.0%-0.12+99.7%-43.73-175.0%58.31-63.9%161.47+34.9%119.69
PBT44.31+181.1%-54.65+60.3%-137.66-357.8%53.39-60.9%136.63+45.2%94.08
Tax-12.0525.0315.68-8.33-32.18-12.03
Equity50.0600000
OPM (%)2.83-3.96-9.643.759.977.91
Net Profit32.26+208.9%-29.61+75.7%-121.98-370.7%45.06-56.9%104.45+27.3%82.05
NPM (%)2.06-2.14-8.553.177.626.90
EPS (Rs)0.88+161.1%-1.44+70.5%-4.88-392.2%1.67-56.8%3.87+34.8%2.87
CEPS0.85-1.44-4.881.653.852.85

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

7
YearTypeAmountEx-Date
2021Final Dividend0.508 Sep 2021
2019Final Dividend0.221 Aug 2019
2018Interim Dividend0.220 Nov 2017
2011Final Dividend1.516 Sep 2011
2010Final Dividend223 Sep 2010
2009Final Dividend102 Sep 2009
2008Final Dividend111 Sep 2008

Bonus

0

No bonus history.

Split

1
YearRatioEx-Date
2016Rs.10/- to Rs.2/-25 Feb 2016
Loading company dashboard...
Fetching ratios, charts, and peers